LabLogic Systems Limited
LabLogic is a worldwide market leader in the supply of LIMS and chromatography data systems to the pharmaceutical, agrochemical and nuclear/PET industries. We also design, manufacture, sell and service instruments used in the measurement of low-level radioactivity. Our products help our customers accelerate their research, providing quality data using industry standard solutions.
LabLogic’s instruments, software and validation services have been providing innovative solutions for the measurement and reporting needs of drug metabolism researchers, scientists in PET laboratories and radio-chemists throughout the world for more than 30 years.
The company has an outstanding reputation for its responsiveness to customers’ needs: on a daily basis through the medium of its technical help desk, which gives immediate and expert assistance; and in the longer term through regular User Meetings, at which customers can influence future product developments.
LabLogic was founded in the UK in 1980 by John Clapham as a supplier of radio TLC and HPLC instruments and associated software to research organisations. IN/US Systems was founded in the USA a decade later by Dr Ed Rapkin to produce, sell and support the company’s β-RAM radio detector. Both founders had worked together in the 1970s and so a mutual co-operation was natural, since both companies’ focus was the needs of drug research.
IN/US produced the β-RAM radio HPLC detector for β-emitters. LabLogic developed software; firstly DEBRA, a LIMS for drug metabolism which became industry standard for ADME studies. Later, application software for radio chromatography, RaChel, running on Windows 3.0 and various generations followed. LabLogic has a long history of user group involvement which has driven continuous development. Further hardware developments for the β-RAM and its derivatives followed from IN/US, either from its own designers or manufacturing LabLogic’s designs under licence.
Applications in TLC, WBA, radio-GC and more recently PET were catered for by the two companies, and both have a commitment to excellent personal support to users. Customers include most drug research organisations, contract laboratories and leading universities spanning 46 countries.